M. Machiavelli

1.3k total citations
32 papers, 1.0k citations indexed

About

M. Machiavelli is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, M. Machiavelli has authored 32 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Oncology, 13 papers in Pulmonary and Respiratory Medicine and 9 papers in Surgery. Recurrent topics in M. Machiavelli's work include Colorectal Cancer Treatments and Studies (12 papers), Cancer Treatment and Pharmacology (8 papers) and Colorectal and Anal Carcinomas (7 papers). M. Machiavelli is often cited by papers focused on Colorectal Cancer Treatments and Studies (12 papers), Cancer Treatment and Pharmacology (8 papers) and Colorectal and Anal Carcinomas (7 papers). M. Machiavelli collaborates with scholars based in Argentina, United States and Portugal. M. Machiavelli's co-authors include Carlos Vallejo, J. Eduardo Pérez, J. Lacava, A. Romero, Maria Cuevas, B Leone, Ricardo Rodríguez, Mario Rabinovich, M. Langhi and Alberto Romero and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Cancer and Annals of Oncology.

In The Last Decade

M. Machiavelli

32 papers receiving 966 citations

Peers

M. Machiavelli

ONCOL

PRM

PFM

SURGE

R. Largillier France

L. Kayitalire France

S. Palmeri Italy

G. Comella Italy

Theresa Gilewski United States

S.H. Goey Netherlands

Jana Barinoff Germany

Eleni Timotheadou Greece

A. Ashworth Canada

Luís Más Peru

R. Largillier France

M. Machiavelli

940 ×1.2

ONCOL

334 ×1.3

PRM

527 ×2.3

231 ×1.2

PFM

201 ×1.3

SURGE

Citations per year, relative to M. Machiavelli M. Machiavelli (= 1×) peers R. Largillier

Countries citing papers authored by M. Machiavelli

Since Specialization

Citations

This map shows the geographic impact of M. Machiavelli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Machiavelli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Machiavelli more than expected).

Fields of papers citing papers by M. Machiavelli

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Machiavelli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Machiavelli. The network helps show where M. Machiavelli may publish in the future.

Co-authorship network of co-authors of M. Machiavelli

This figure shows the co-authorship network connecting the top 25 collaborators of M. Machiavelli. A scholar is included among the top collaborators of M. Machiavelli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Machiavelli. M. Machiavelli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Leone, Bernardo Amadeo, Carlos Vallejo, Alberto Romero, et al.. (2016). Prognostic impact of metastatic pattern in stage IV breast cancer at initial diagnosis. Breast Cancer Research and Treatment. 161(3). 537–548. 67 indexed citations

Zwenger, Ariel Osvaldo, José Pablo Leone, Carlos Vallejo, et al.. (2011). Treatment of Early Breast Cancer, a Long-term Follow-up Study: The GOCS Experience. The Breast Journal. 17(6). 630–637. 4 indexed citations

Machiavelli, M., Ghada M. Salum, Eduardo Ortíz, et al.. (2004). Double Modulation of 5-Fluorouracil by Trimetrexate and Leucovorin in Patients With Advanced Colorectal Carcinoma. American Journal of Clinical Oncology. 27(2). 149–154. 2 indexed citations

Vallejo, Carlos, M. Machiavelli, J. Eduardo Pérez, et al.. (2003). Docetaxel as Neoadjuvant Chemotherapy in Patients With Advanced Cervical Carcinoma. American Journal of Clinical Oncology. 26(5). 477–482. 15 indexed citations

Pérez, J. Eduardo, M. Machiavelli, Alberto Romero, et al.. (2002). Vinorelbine and Paclitaxel for Locoregional Advanced or Metastatic Non–Small-Cell Lung Cancer. American Journal of Clinical Oncology. 25(4). 383–387. 4 indexed citations

Paradiso, Angelo, G. Simone, B Leone, et al.. (2000). Thymidilate synthase and p53 primary tumour expression as predictive factors for advanced colorectal cancer patients. British Journal of Cancer. 82(3). 560–567. 122 indexed citations

Pérez, J. Eduardo, J. Lacava, Ricardo Rodríguez, et al.. (1998). Biochemical Modulation of 5-Fluorouracil by Methotrexate in Patients With Advanced Gastric Carcinoma. American Journal of Clinical Oncology. 21(5). 452–457. 10 indexed citations

Romero, Alberto, J. Eduardo Pérez, Maria Cuevas, et al.. (1998). Double Modulation of 5-Fluorouracil by Methotrexate and High-Dose L-Leucovorin in Advanced Colorectal Cancer. American Journal of Clinical Oncology. 21(1). 94–98. 3 indexed citations

Lorusso, Vito, Giovanni Di Vagno, Luigi Manzione, et al.. (1998). Combined Carboplatin plus Ifosfamide and Cisplatin in Patients with Advanced Ovarian Carcinoma. A Phase I–II Study. Gynecologic Oncology. 68(2). 172–177. 5 indexed citations

10.

Pérez, J. Eduardo, J. Lacava, Ricardo Rodríguez, et al.. (1998). Biomodulation with Sequential Intravenous IFN-α2b and 5-Fluorouracil as Second-Line Treatment in Patients with Advanced Colorectal Cancer. Journal of Interferon & Cytokine Research. 18(8). 565–569. 3 indexed citations

11.

Paradiso, Angelo, Mario Rabinovich, Carlos Vallejo, et al.. (1996). p53 and PCNA expression in advanced colorectal cancer: Response to chemotherapy and long-term prognosis. International Journal of Cancer. 69(6). 437–441. 50 indexed citations

12.

Vallejo, Carlos, J. Eduardo Pérez, Maria Cuevas, et al.. (1996). Ifosfamide and Cisplatin as Neoadjuvant Chemotherapy for Advanced Cervical Carcinoma. American Journal of Clinical Oncology. 19(2). 132–135. 39 indexed citations

13.

Pérez, J. Eduardo, M. Machiavelli, B Leone, et al.. (1995). High-Dose Cisplatin with Dipyridamole in Advanced Non-Small Cell Lung Cancer. American Journal of Clinical Oncology. 18(3). 185–188. 6 indexed citations

14.

Piedbois, Pascal, Marc Buyse, G.H. Blijham, et al.. (1994). Meta-analysis of randomized trials testing the biochemical modulation of fluorouracil by methotrexate in metastatic colorectal cancer. Journal of Clinical Oncology. 12(5). 960–969. 162 indexed citations

15.

Romero, A., Mario Rabinovich, Carlos Vallejo, et al.. (1994). Vinorelbine as first-line chemotherapy for metastatic breast carcinoma.. Journal of Clinical Oncology. 12(2). 336–341. 168 indexed citations

16.

Lena, M. De, A. Romero, Mario Rabinovich, et al.. (1993). Metastatic Pattern and DNA Ploidy in Stage IV Breast Cancer at Initial Diagnosis. American Journal of Clinical Oncology. 16(3). 245–249. 6 indexed citations

17.

Pérez, J. Eduardo, M. Machiavelli, B Leone, et al.. (1993). Ifosfamide and mitoxantrone as first-line chemotherapy for metastatic breast cancer.. Journal of Clinical Oncology. 11(3). 461–466. 4 indexed citations

18.

Rabinovich, Mario, Carlos Vallejo, J. Eduardo Pérez, et al.. (1992). Development and Validation of Prognostic Models in Metastatic Breast Cancer: A GOCS Study. Oncology. 49(3). 188–195. 11 indexed citations

19.

Pérez, J. Eduardo, M. Machiavelli, B Leone, et al.. (1990). Bone-Only Versus Visceral-Only Metastatic Pattern in Breast Cancer. American Journal of Clinical Oncology. 13(4). 294–298. 44 indexed citations

20.

Machiavelli, M., Alberto Romero, J. Eduardo Pérez, et al.. (1989). Relation between Delay and Survival in 596 Patients with Breast Cancer. Oncology. 46(2). 78–82. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact